{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:50:53Z","timestamp":1783471853161,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29252-3","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T11:04:28Z","timestamp":1764068668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive analysis of Guanfacine treatment in autism spectrum disorder with comorbid attention deficit hyperactivity disorder"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9631-1262","authenticated-orcid":false,"given":"Cansu","family":"\u00c7obano\u011flu Osmanl\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3398-6876","authenticated-orcid":false,"given":"Saliha","family":"Baykal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2818-4764","authenticated-orcid":false,"given":"Bedia Sultan","family":"\u00d6nal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4699-3418","authenticated-orcid":false,"given":"Berkan","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8359-6131","authenticated-orcid":false,"given":"Abdullah","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"29252_CR1","doi-asserted-by":"publisher","unstructured":"Maenner, M. J. Prevalence and characteristics of autism spectrum disorder among children aged 8 years\u2014Autism and developmental disabilities monitoring Network, 11 sites, united States, 2020. MMWR Surveillance Summaries 72. https:\/\/doi.org\/10.15585\/mmwr.ss7202a1 (2023).","DOI":"10.15585\/mmwr.ss7202a1"},{"issue":"1","key":"29252_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/acps.12644","volume":"135","author":"K Jobski","year":"2017","unstructured":"Jobski, K. et al. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review. Acta Psychiatry. Scand. 135(1), 8\u201328. https:\/\/doi.org\/10.1111\/acps.12644 (2017).","journal-title":"Acta Psychiatry. Scand."},{"key":"29252_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10803-006-0125-y","volume":"36","author":"AV Brereton","year":"2006","unstructured":"Brereton, A. V., Tonge, B. J. & Einfeld, S. L. Psychopathology in children and adolescents with autism compared to young people with intellectual disability. J. Autism Dev. Disord. 36, 863\u2013870. https:\/\/doi.org\/10.1007\/s10803-006-0125-y (2006).","journal-title":"J. Autism Dev. Disord."},{"key":"29252_CR4","doi-asserted-by":"publisher","first-page":"112922","DOI":"10.1016\/j.psychres.2020.112922","volume":"287","author":"MM Hossain","year":"2020","unstructured":"Hossain, M. M. et al. Prevalence of comorbid psychiatric disorders among people with autism spectrum disorder: an umbrella review of systematic reviews and meta-analyses. Psychiatry Res. 287, 112922. https:\/\/doi.org\/10.1016\/j.psychres.2020.112922 (2020).","journal-title":"Psychiatry Res."},{"issue":"1","key":"29252_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.rasd.2010.06.012","volume":"5","author":"SD Mayes","year":"2011","unstructured":"Mayes, S. D. et al. Anxiety, depression, and irritability in children with autism relative to other neuropsychiatric disorders and typical development. Res. Autism Spectr. Disorders. 5(1), 474\u2013485. https:\/\/doi.org\/10.1016\/j.rasd.2010.06.012 (2011).","journal-title":"Res. Autism Spectr. Disorders"},{"key":"29252_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ridd.2016.11.009","volume":"60","author":"R Mansour","year":"2017","unstructured":"Mansour, R. et al. ADHD severity as it relates to comorbid psychiatric symptomatology in children with autism spectrum disorders (ASD). Res. Dev. Disabil. 60, 52\u201364. https:\/\/doi.org\/10.1016\/j.ridd.2016.11.009 (2017).","journal-title":"Res. Dev. Disabil."},{"key":"29252_CR7","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s10803-010-1158-9","volume":"41","author":"S Georgiades","year":"2011","unstructured":"Georgiades, S. et al. Phenotypic overlap between core diagnostic features and emotional\/behavioral problems in preschool children with autism spectrum disorder. J. Autism Dev. Disord. 41, 1321\u20131329. https:\/\/doi.org\/10.1007\/s10803-010-1158-9 (2011).","journal-title":"J. Autism Dev. Disord."},{"key":"29252_CR8","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s10803-006-0147-5","volume":"36","author":"L Lecavalier","year":"2006","unstructured":"Lecavalier, L. Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification. J. Autism Dev. Disord. 36, 1101\u20131114. https:\/\/doi.org\/10.1007\/s10803-006-0147-5 (2006).","journal-title":"J. Autism Dev. Disord."},{"issue":"1","key":"29252_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/104454604773840481","volume":"14","author":"KA Stigler","year":"2004","unstructured":"Stigler, K. A. et al. A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. J. Child Adolesc. Psychopharmacol. 14(1), 49\u201356. https:\/\/doi.org\/10.1089\/104454604773840481 (2004).","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"5","key":"29252_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/00004583-199905000-00011","volume":"38","author":"LL Greenhill","year":"1999","unstructured":"Greenhill, L. L., Halperin, J. M. & Abikoff, H. Stimulant medications. J. Am. Acad. Child. Adolesc. Psychiatry. 38(5), 503\u2013512. https:\/\/doi.org\/10.1097\/00004583-199905000-00011 (1999).","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"issue":"1","key":"29252_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1087054714559643","volume":"21","author":"CRM Maia","year":"2017","unstructured":"Maia, C. R. M. et al. Long-term efficacy of methylphenidate immediate-release for the treatment of childhood ADHD: a systematic review and meta-analysis. J. Atten. Disord. 21(1), 3\u201313. https:\/\/doi.org\/10.1177\/1087054714559643 (2017).","journal-title":"J. Atten. Disord."},{"issue":"5","key":"29252_CR12","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cpr.2007.10.007","volume":"28","author":"S Van der Oord","year":"2008","unstructured":"Van der Oord, S. et al. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. Clin. Psychol. Rev. 28(5), 783\u2013800. https:\/\/doi.org\/10.1016\/j.cpr.2007.10.007 (2008).","journal-title":"Clin. Psychol. Rev."},{"issue":"11","key":"29252_CR13","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/archpsyc.62.11.1266","volume":"62","author":"P Autism","year":"2005","unstructured":"Autism, P. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch. Gen. Psychiatry. 62(11), 1266\u20131274. https:\/\/doi.org\/10.1001\/archpsyc.62.11.1266 (2005).","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"29252_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0269881117741766","volume":"32","author":"OD Howes","year":"2018","unstructured":"Howes, O. D. et al. Autism spectrum disorder: consensus guidelines on assessment, treatment and research from the British association for psychopharmacology. J. Psychopharmacol. 32(1), 3\u201329. https:\/\/doi.org\/10.1177\/0269881117741766 (2018).","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"29252_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/00004583-200102000-00012","volume":"40","author":"LL Greenhill","year":"2001","unstructured":"Greenhill, L. L. et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA Titration trial. J. Am. Acad. Child. Adolesc. Psychiatry. 40(2), 180\u2013187. https:\/\/doi.org\/10.1097\/00004583-200102000-00012 (2001).","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"29252_CR16","doi-asserted-by":"publisher","unstructured":"Mahajan, R. et al. Clinical practice pathways for evaluation and medication choice for attention-deficit\/hyperactivity disorder symptoms in autism spectrum disorders. Pediatrics 130(Supplement_2), S125\u2013S138. https:\/\/doi.org\/10.1542\/peds.2012-0900J (2012).","DOI":"10.1542\/peds.2012-0900J"},{"issue":"3","key":"29252_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/DBP.0000000000001028","volume":"43","author":"E Fombonne","year":"2022","unstructured":"Fombonne, E. et al. Emotional and behavioral problems in youth with autism: high prevalence and impact on functioning. J. Dev. Behav. Pediatr. 43(3), 140\u2013148. https:\/\/doi.org\/10.1097\/DBP.0000000000001028 (2022).","journal-title":"J. Dev. Behav. Pediatr."},{"issue":"Supplement_2","key":"29252_CR18","doi-asserted-by":"publisher","first-page":"pS124","DOI":"10.1542\/peds.2015-2851K","volume":"137","author":"LK Fung","year":"2016","unstructured":"Fung, L. K. et al. Pharmacologic treatment of severe irritability and problem behaviors in autism: a systematic review and meta-analysis. Pediatrics 137(Supplement_2), pS124\u2013S135. https:\/\/doi.org\/10.1542\/peds.2015-2851K (2016).","journal-title":"Pediatrics"},{"issue":"2","key":"29252_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10802-013-9778-0","volume":"42","author":"W Mandy","year":"2014","unstructured":"Mandy, W., Roughan, L. & Skuse, D. Three dimensions of oppositionality in autism spectrum disorder. J. Abnorm. Child. Psychol. 42(2), 291\u2013300. https:\/\/doi.org\/10.1007\/s10802-013-9778-0 (2014).","journal-title":"J. Abnorm. Child. Psychol."},{"issue":"11","key":"29252_CR20","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1469-7610.2012.02600.x","volume":"53","author":"E Simonoff","year":"2012","unstructured":"Simonoff, E. et al. Severe mood problems in adolescents with autism spectrum disorder. J. Child Psychol. Psychiatry. 53(11), 1157\u20131166. https:\/\/doi.org\/10.1111\/j.1469-7610.2012.02600.x (2012).","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"5","key":"29252_CR21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJMoa013171","volume":"347","author":"JT McCracken","year":"2002","unstructured":"McCracken, J. T. et al. Risperidone in children with autism and serious behavioral problems. N. Engl. J. Med. 347(5), 314\u2013321. https:\/\/doi.org\/10.1056\/NEJMoa013171 (2002).","journal-title":"N. Engl. J. Med."},{"key":"29252_CR22","doi-asserted-by":"publisher","first-page":"JCNSD","DOI":"10.4137\/JCNSD.S4140","volume":"3","author":"P Douglas-Hall","year":"2011","unstructured":"Douglas-Hall, P. et al. Aripiprazole: A review of its use in the treatment of irritability associated with autistic disorder patients aged 6\u201317. J. Cent. Nerv. Syst. Disease. 3, JCNSD. https:\/\/doi.org\/10.4137\/JCNSD.S4140 (2011).","journal-title":"J. Cent. Nerv. Syst. Disease"},{"issue":"15","key":"29252_CR23","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1517\/14656566.2012.721778","volume":"13","author":"OG Bukstein","year":"2012","unstructured":"Bukstein, O. G. & Head, J. Guanfacine ER for the treatment of adolescent attention-deficit\/hyperactivity disorder. Expert Opin. Pharmacother. 13(15), 2207\u20132213. https:\/\/doi.org\/10.1517\/14656566.2012.721778 (2012).","journal-title":"Expert Opin. Pharmacother."},{"issue":"12","key":"29252_CR24","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1176\/appi.ajp.2015.15010055","volume":"172","author":"L Scahill","year":"2015","unstructured":"Scahill, L. et al. Extended-release Guanfacine for hyperactivity in children with autism spectrum disorder. Am. J. Psychiatry. 172(12), 1197\u20131206. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15010055 (2015).","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"29252_CR25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5498\/wjp.v13.i6.262","volume":"13","author":"J Hellings","year":"2023","unstructured":"Hellings, J. Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials. World J. Psychiatry. 13(6), 262. https:\/\/doi.org\/10.5498\/wjp.v13.i6.262 (2023).","journal-title":"World J. Psychiatry"},{"issue":"8","key":"29252_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archpsyc.1992.01820080023004","volume":"49","author":"NC Andreasen","year":"1992","unstructured":"Andreasen, N. C., Flaum, M. & Arndt, S. The comprehensive assessment of symptoms and history (CASH): an instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry. 49(8), 615\u2013623. https:\/\/doi.org\/10.1001\/archpsyc.1992.01820080023004 (1992).","journal-title":"Arch. Gen. Psychiatry"},{"key":"29252_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1023\/A:1022602400621","volume":"26","author":"CK Conners","year":"1998","unstructured":"Conners, C. K. et al. The revised conners\u2019 parent rating scale (CPRS-R): factor structure, reliability, and criterion validity. J. Abnorm. Child. Psychol. 26, 257\u2013268. https:\/\/doi.org\/10.1023\/A:1022602400621 (1998).","journal-title":"J. Abnorm. Child. Psychol."},{"issue":"2","key":"29252_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4274\/npa.y6219","volume":"50","author":"S Kaner","year":"2013","unstructured":"Kaner, S., B\u00fcy\u00fck\u00f6zt\u00fcrk, S. & Iseri, E. Conners Anababa dereceleme \u00d6l\u00e7egi-Yenilenmis kisa: T\u00fcrkiye Stardardizasyon \u00c7alismasi\/Conners parent rating Scale-Revised short: Turkish standardization study. Noro-Psikyatri Arsivi. 50(2), 100. https:\/\/doi.org\/10.4274\/npa.y6219 (2013).","journal-title":"Noro-Psikyatri Arsivi"},{"key":"29252_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1023\/A:1022606501530","volume":"26","author":"CK Conners","year":"1998","unstructured":"Conners, C. K. et al. Revision and restandardization of the Conners teacher rating scale (CTRS-R): factor structure, reliability, and criterion validity. J. Abnorm. Child. Psychol. 26, 279\u2013291. https:\/\/doi.org\/10.1023\/A:1022606501530 (1998).","journal-title":"J. Abnorm. Child. Psychol."},{"key":"29252_CR30","doi-asserted-by":"crossref","unstructured":"Kaner, S., Buyukuzturk, S. & \u0130\u015eER\u0130, E. Conners teacher rating scale-revised short: Turkish adaptation study. Educ. Sci., 38(167). (2013).","DOI":"10.15390\/ES.2013.1104"},{"key":"29252_CR31","doi-asserted-by":"publisher","DOI":"10.1037\/t49458-000","author":"E Schopler","year":"1980","unstructured":"Schopler, E. et al. Toward objective classification of childhood autism: childhood autism rating scale (CARS). J. Autism Dev. Disord. https:\/\/doi.org\/10.1037\/t49458-000 (1980).","journal-title":"J. Autism Dev. Disord."},{"key":"29252_CR32","first-page":"116","volume":"4","author":"NB Sucuo\u011flu","year":"1996","unstructured":"Sucuo\u011flu, N. B., Akk\u00f6k, F., Bahar, G. & \u00d6ktem, F. A study on scales used in the evaluation of autistic children. J. Psychiatry Psychol. Psychopharmacol. 4, 116\u2013121 (1996).","journal-title":"J. Psychiatry Psychol. Psychopharmacol."},{"issue":"5","key":"29252_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1037\/t10453-000","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman, M. G. et al. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am. J. Ment. Defic. 89(5), 485\u2013491. https:\/\/doi.org\/10.1037\/t10453-000 (1985).","journal-title":"Am. J. Ment. Defic."},{"key":"29252_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10578-008-0108-7","volume":"40","author":"K Karabekiroglu","year":"2009","unstructured":"Karabekiroglu, K. & Aman, M. G. Validity of the aberrant behavior checklist in a clinical sample of toddlers. Child Psychiatry Hum. Dev. 40, 99\u2013110. https:\/\/doi.org\/10.1007\/s10578-008-0108-7 (2009).","journal-title":"Child Psychiatry Hum. Dev."},{"key":"29252_CR35","doi-asserted-by":"publisher","unstructured":"Guy, W. Clinical global impression. Assess. Man. Psychopharmacol. p217\u2013p222. https:\/\/doi.org\/10.1037\/e591322011-001 (1976).","DOI":"10.1037\/e591322011-001"},{"issue":"1","key":"29252_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/aca.ACA_157_18","volume":"22","author":"P Mishra","year":"2019","unstructured":"Mishra, P. et al. Descriptive statistics and normality tests for statistical data. Ann. Card. Anaesth. 22(1), 67\u201372. https:\/\/doi.org\/10.4103\/aca.ACA_157_18 (2019).","journal-title":"Ann. Card. Anaesth."},{"issue":"4","key":"29252_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4103\/aca.ACA_94_19","volume":"22","author":"P Mishra","year":"2019","unstructured":"Mishra, P. et al. Application of student\u2019s t-test, analysis of variance, and covariance. Ann. Card. Anaesth. 22(4), 407\u2013411. https:\/\/doi.org\/10.4103\/aca.ACA_94_19 (2019).","journal-title":"Ann. Card. Anaesth."},{"key":"29252_CR38","unstructured":"Hayes, A. F. Introduction To mediation, moderation, and Conditional Process Analysis: A regression-based Approach (Vol.3) (The Guilford Press, 2022)."},{"key":"29252_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ridd.2017.09.009","volume":"70","author":"MB McClain","year":"2017","unstructured":"McClain, M. B., Mills, A. M. H. & Murphy, L. E. Inattention and hyperactivity\/impulsivity among children with attention-deficit\/hyperactivity-disorder, autism spectrum disorder, and intellectual disability. Res. Dev. Disabil. 70, 175\u2013184. https:\/\/doi.org\/10.1016\/j.ridd.2017.09.009 (2017).","journal-title":"Res. Dev. Disabil."},{"issue":"8","key":"29252_CR40","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/s41386-018-0039-3","volume":"43","author":"LC Politte","year":"2018","unstructured":"Politte, L. C. et al. A randomized, placebo-controlled trial of extended-release Guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures. Neuropsychopharmacology 43(8), 1772\u20131778. https:\/\/doi.org\/10.1038\/s41386-018-0039-3 (2018).","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"29252_CR41","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner, J. & Targum, S. D. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (edgmont). 4(7), 28 (2007).","journal-title":"Psychiatry (edgmont)"},{"issue":"10","key":"29252_CR42","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.npp.1301147","volume":"31","author":"S Leucht","year":"2006","unstructured":"Leucht, S. et al. Linking the PANSS, BPRS, and CGI: clinical implications. Neuropsychopharmacology 31(10), 2318\u20132325. https:\/\/doi.org\/10.1038\/sj.npp.1301147 (2006).","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"29252_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1469-8749.2008.03178.x","volume":"51","author":"S Goldman","year":"2009","unstructured":"Goldman, S. et al. Motor stereotypies in children with autism and other developmental disorders. Dev. Med. Child. Neurol. 51(1), 30\u201338. https:\/\/doi.org\/10.1111\/j.1469-8749.2008.03178.x (2009).","journal-title":"Dev. Med. Child. Neurol."},{"issue":"6","key":"29252_CR44","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/1469-7610.00502","volume":"40","author":"M Turner","year":"1999","unstructured":"Turner, M. & Annotation Repetitive behaviour in autism: A review of psychological research. J. Child. Psychol. Psychiatry Allied Disciplines. 40(6), 839\u2013849. https:\/\/doi.org\/10.1111\/1469-7610.00502 (1999).","journal-title":"J. Child. Psychol. Psychiatry Allied Disciplines"},{"issue":"6","key":"29252_CR45","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/aur.103","volume":"2","author":"BE Yerys","year":"2009","unstructured":"Yerys, B. E. et al. Attention deficit\/hyperactivity disorder symptoms moderate cognition and behavior in children with autism spectrum disorders. Autism Res. 2(6), 322\u2013333. https:\/\/doi.org\/10.1002\/aur.103 (2009).","journal-title":"Autism Res."},{"issue":"15","key":"29252_CR46","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1001\/jama.2015.3150","volume":"313","author":"K Bearss","year":"2015","unstructured":"Bearss, K. et al. Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: A randomized clinical trial. Jama 313(15), 1524\u20131533. https:\/\/doi.org\/10.1001\/jama.2015.3150 (2015).","journal-title":"Jama"},{"issue":"2","key":"29252_CR47","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jaac.2011.11.010","volume":"51","author":"L Scahill","year":"2012","unstructured":"Scahill, L. et al. Effects of Risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. J. Am. Acad. Child. Adolesc. Psychiatry. 51(2), 136\u2013146. https:\/\/doi.org\/10.1016\/j.jaac.2011.11.010 (2012).","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"issue":"4","key":"29252_CR48","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.chc.2008.06.009","volume":"17","author":"MG Aman","year":"2008","unstructured":"Aman, M. G. et al. Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child Adolesc. Psychiatr. Clin. N. Am. 17(4), 713\u2013738. https:\/\/doi.org\/10.1016\/j.chc.2008.06.009 (2008).","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"issue":"12","key":"29252_CR49","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1469-7610.2007.01799.x","volume":"48","author":"S Brieber","year":"2007","unstructured":"Brieber, S. et al. Structural brain abnormalities in adolescents with autism spectrum disorder and patients with attention deficit\/hyperactivity disorder. J. Child Psychol. Psychiatry. 48(12), 1251\u20131258. https:\/\/doi.org\/10.1111\/j.1469-7610.2007.01799.x (2007).","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"2","key":"29252_CR50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/mp.2011.185","volume":"18","author":"A Christakou","year":"2013","unstructured":"Christakou, A. et al. Disorder-specific functional abnormalities during sustained attention in youth with attention deficit hyperactivity disorder (ADHD) and with autism. Mol. Psychiatry. 18(2), 236\u2013244. https:\/\/doi.org\/10.1038\/mp.2011.185 (2013).","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"29252_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12402-012-0086-2","volume":"4","author":"R Taurines","year":"2012","unstructured":"Taurines, R. et al. ADHD and autism: differential diagnosis or overlapping traits? A selective review. ADHD Atten. Deficit Hyperactivity Disorders. 4(3), 115\u2013139. https:\/\/doi.org\/10.1007\/s12402-012-0086-2 (2012).","journal-title":"ADHD Atten. Deficit Hyperactivity Disorders"},{"issue":"6","key":"29252_CR52","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/CHI.0b013e31816bff88","volume":"47","author":"AM Reiersen","year":"2008","unstructured":"Reiersen, A. M., Constantino, J. N. & Todd, R. D. Co-occurrence of motor problems and autistic symptoms in attention-deficit\/hyperactivity disorder. J. Am. Acad. Child. Adolesc. Psychiatry. 47(6), 662\u2013672. https:\/\/doi.org\/10.1097\/CHI.0b013e31816bff88 (2008).","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"issue":"5","key":"29252_CR53","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1469-7610.2006.01720.x","volume":"48","author":"AM Reiersen","year":"2007","unstructured":"Reiersen, A. M. et al. Autistic traits in a population-based ADHD twin sample. J. Child Psychol. Psychiatry. 48(5), 464\u2013472. https:\/\/doi.org\/10.1111\/j.1469-7610.2006.01720.x (2007).","journal-title":"J. Child Psychol. Psychiatry"},{"key":"29252_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-021-01292-2","volume":"23","author":"RP Thom","year":"2021","unstructured":"Thom, R. P. et al. Recent updates in psychopharmacology for the core and associated symptoms of autism spectrum disorder. Curr. Psychiatry Rep. 23, 1\u20139. https:\/\/doi.org\/10.1007\/s11920-021-01292-2 (2021).","journal-title":"Curr. Psychiatry Rep."},{"key":"29252_CR55","doi-asserted-by":"publisher","unstructured":"Stahl, S. M. Stahl\u2019s essential psychopharmacology: neuroscientific basis and practical applications (Cambridge University Press, 2021). https:\/\/doi.org\/10.1017\/9781108975292.","DOI":"10.1017\/9781108975292"},{"key":"29252_CR56","doi-asserted-by":"publisher","unstructured":"Salloum-Asfar, S., Zawia, N. & Abdulla, S. A. Retracing our steps: A review on autism research in children, its limitation and impending Pharmacological interventions. Pharmacol. Ther. 108564. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108564 (2023).","DOI":"10.1016\/j.pharmthera.2023.108564"},{"key":"29252_CR57","doi-asserted-by":"publisher","first-page":"110326","DOI":"10.1016\/j.pnpbp.2021.110326","volume":"110","author":"AM Persico","year":"2021","unstructured":"Persico, A. M. et al. The pediatric psychopharmacology of autism spectrum disorder: A systematic review-Part I: the past and the present. Prog. Neuropsychopharmacol. Biol. Psychiatry. 110, 110326. https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110326 (2021).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"29252_CR58","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1542\/peds.2006-3695","volume":"121","author":"J Biederman","year":"2008","unstructured":"Biederman, J. et al. A randomized, double-blind, placebo-controlled study of Guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder. Pediatrics 121(1), e73\u2013e84. https:\/\/doi.org\/10.1542\/peds.2006-3695 (2008).","journal-title":"Pediatrics"},{"issue":"1","key":"29252_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/cap.2016.0132","volume":"27","author":"JR Strawn","year":"2017","unstructured":"Strawn, J. R. et al. Extended release Guanfacine in pediatric anxiety disorders: a pilot, randomized, placebo-controlled trial. J. Child Adolesc. Psychopharmacol. 27(1), 29\u201337. https:\/\/doi.org\/10.1089\/cap.2016.0132 (2017).","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"29252_CR60","unstructured":"Hoffman, B. B. Catecholamines, Sympathomimetic drugs, and Adrenergic Receptors Antagonists (Goodman and Gilman\u2019s the pharmacological basis of therapeutics, 2001)."},{"key":"29252_CR61","doi-asserted-by":"publisher","unstructured":"Martinez-Raga, J., Knecht, C. & de Alvaro, R. Profile of Guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder. Neuropsychiatr. Dis. Treat. 1359\u20131370. https:\/\/doi.org\/10.2147\/NDT.S65735 (2015).","DOI":"10.2147\/NDT.S65735"},{"issue":"5","key":"29252_CR62","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1089\/cap.2013.0028","volume":"23","author":"F Sallee","year":"2013","unstructured":"Sallee, F., Connor, D. F. & Newcorn, J. H. A review of the rationale and clinical utilization of \u03b12-adrenoceptor agonists for the treatment of attention-deficit\/hyperactivity and related disorders. J. Child Adolesc. Psychopharmacol. 23(5), 308\u2013319. https:\/\/doi.org\/10.1089\/cap.2013.0028 (2013).","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"2","key":"29252_CR63","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/CHI.0b013e318191769e","volume":"48","author":"FR Sallee","year":"2009","unstructured":"Sallee, F. R. et al. Guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder: a placebo-controlled trial. J. Am. Acad. Child. Adolesc. Psychiatry. 48(2), 155\u2013165. https:\/\/doi.org\/10.1097\/CHI.0b013e318191769e (2009).","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"issue":"3","key":"29252_CR64","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.braindev.2013.04.013","volume":"36","author":"A Lo-Castro","year":"2014","unstructured":"Lo-Castro, A. & Curatolo, P. Epilepsy associated with autism and attention deficit hyperactivity disorder: is there a genetic link? Brain Develop. 36(3), 185\u2013193. https:\/\/doi.org\/10.1016\/j.braindev.2013.04.013 (2014).","journal-title":"Brain Develop."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29252-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29252-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29252-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:43:12Z","timestamp":1777128192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29252-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["29252"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29252-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45310"}}